Moteur de recherche d’entreprises européennes

Financement de l’UE (15,3 M €) : Création d’un écosystème pour un meilleur suivi et une meilleure communication de l’innocuité des médicaments pendant la grossesse et l’allaitement : des flux de … Hor01/04/2019 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Création d’un écosystème pour un meilleur suivi et une meilleure communication de l’innocuité des médicaments pendant la grossesse et l’allaitement : des flux de travail validés et approuvés par les autorités réglementaires pour une génération rapide et optimisée de données probantes

ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation. What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety in pregnancy. We will establish (1) a successful, sustainable open-science based EU non-proprietary ecosystem of public and private stakeholders, pregnant women and researchers to generate and disseminate timely and reliable evidence on drugs across maternal, neonatal and long term outcomes of medication exposure in pregnancy and breastfeeding (2) a catalogue with fully characterized data sources for rapid selection of suitable data sources; 3) operational, business, network, information and data governance models, (4) quality assured and tested methodological approaches, analytical tools and data platforms allowing for distributed analyses, (5) procedures and tools for collection of digital data and samples directly from pregnant women, (6) In vitro, in silico and in vivo models for prediction of drug transfer in human milk, (7) a biobank and analytical network for quantification of drug in human milk, (8) best practice documents endorsed by regulators and health authorities and (9) a web-based drug information knowledge bank. How do we deliver? (1) Experienced leaders, able to manage challenging networks and public-public or public-private partnerships. (2) Defragmentation by connecting all key stakeholders and EU networks in this area. (3) Re-use of data, tools and foreground from prior European commission funded projects. (4) Connecting to leaders of similar initiatives in the USA, Canada, Asia and other parts of the world. (5) Systematic consensus & endorsement building. (6) Quality throughout as a precondition to trust the results and information by all users.


ABBVIE Inc. 0,00 €
ACADEMISCH ZIEKENHUIS GRONINGEN 260 939 €
Agenzia Regionale Di Sanita 359 110 €
Alma Mater Studiorum - Universita Di Bologna 832 760 €
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) 328 420 €
Bionotus 676 038 €
BRISTOL-MYERS SQUIBB COMPANY Corp. 0,00 €
Centre Hospitalier Universitaire de Toulouse 912 929 €
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS 482 806 €
Consiglio Nazionale Delle Ricerche 143 223 €
ELEVATE B.V. 114 919 €
Eli Lilly and Company Ltd. 0,00 €
Ellegaard Gottingen Minipigs AS 0,00 €
European Forum for Good Clinical Practice 71 648 €
European Institute of Women's Health CLG 135 160 €
Fundacion para El Fomento de La Investigacion Sanitaria y Biomedica de La Comunitat Valenciana 89 869 €
Glaxosmithkline Research & Development Ltd. 0,00 €
Hospices Civils de Lyon 0,00 €
Institut National de la Sante et de la Recherche Medicale 60 721 €
Izmir Katip Celebi Universitesi 0,00 €
Janssen Pharmaceutica N.V. 0,00 €
Karolinska Institutet 10 266,91 €
Katholieke Universiteit Leuven 1 062 746 €
Labcorp Early Development Laboratories Ltd. 0,00 €
Manchester University NHS Foundation Trust 0,00 €
Masarykova Univerzita 0,00 €
Medicines and Healthcare Products Regulatory Agency 60 597 €
Medizinische Universitat Graz 0,00 €
MERCK KGaA 0,00 €
MINISTRY OF HEALTH 0,00 €
Nearshore Macedonia Ltd. Skopje 0,00 €
NOVARTIS PHARMA AG 0,00 €
Novo Nordisk A/S 0,00 €
ORCION B.V. 235 314 €
Pfizer Ltd. 0,00 €
PNO Life Sciences & Health B.V. 41 638 €
Region Stockholm 89 000 €
Region Syddanmark 0,00 €
Region Uppsala 96 896 €
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU 107 321 €
Sanofi-Aventis Recherche & Developpement 0,00 €
SHAMIR HEALTH CORPORATION 0,00 €
Srebrnjak Children's Hospital 0,00 €
St George's Hospital Medical School 370 324 €
STICHTING ENTIS (EUROPEAN NETWORK TERATOLOGY INFORMATION SERVICES) Foundation 390 862 €
STICHTING LAREB 866 023 €
Swansea University 187 844 €
Synergist Services 0,00 €
Takeda Development Centre Europe Ltd. 0,00 €
TAKEDA PHARMACEUTICALS INTERNATIONAL AG 0,00 €
TERVEYDEN JA HYVINVOINNIN LAITOS 283 161 €
TEVA PHARMACEUTICAL INDUSTRIES Ltd. 0,00 €
THE European Institute for Innovation Through Health Data 446 011 €
THE EUROPEAN MEDICINES AGENCY 33 158 €
The Newcastle Upon Tyne Hospitals NHS Foundation Trust 602 464 €
THE Synergist 316 464 €
The University of Manchester 390 398 €
UCB Biopharma 0,00 €
Universita Degli Studi Di Ferrara 238 532 €
UNIVERSITAET LEIPZIG 0,00 €
UNIVERSITAIR MEDISCH CENTRUM UTRECHT 2 486 436 €
UNIVERSITE DE GENEVE 0,00 €
Universitetet I Oslo 806 665 €
University OF Kwazulu-Natal 122 638 €
University of Ulster 692 410 €
Uniwersytet Medyczny im Piastow Slaskich WE Wroclawiu 0,00 €
Uppsala Universitet 894 281 €

https://cordis.europa.eu/project/id/821520

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.